XENETIC BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
XENETIC BIOSCIENCES, INC. (XBIO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 10.28 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-22.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-22
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 13.45M shares, a 99.17% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 10.16M shares, a 61.40% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 8.75M shares, a 39.09% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 8.75M shares, a 40.31% increase year-over-year.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 10.28M shares, a 60.81% increase from fiscal 2020.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 6.39M shares, a 124.10% increase from fiscal 2019.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.85M shares, a 277.30% increase from fiscal 2018.
- XENETIC BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 756.01K shares, a 91.28% decline from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 13.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 11.80M shares derived: average of 2 quarters · filed 2022-03-22 | 10.79M shares derived: average of 3 quarters · filed 2022-03-22 | 10.28M shares 10-K · filed 2022-03-22 | ||||
| 2021-09-30 | 10.16M shares 10-Q · filed 2021-11-12 | 9.45M shares derived: average of 2 quarters · filed 2021-11-12 | 9.22M shares 10-Q · filed 2021-11-12 | 8.60M shares derived: average of 4 quarters · filed 2022-03-22 | ||||
| 2021-06-30 | 8.75M shares 10-Q · filed 2021-08-12 | 8.75M shares 10-Q · filed 2021-08-12 | 8.08M shares derived: average of 3 quarters · filed 2022-03-22 | 7.64M shares derived: average of 4 quarters · filed 2022-03-22 | ||||
| 2021-03-31 | 8.75M shares 10-Q · filed 2021-05-11 | 7.75M shares derived: average of 2 quarters · filed 2022-03-22 | 7.26M shares derived: average of 3 quarters · filed 2022-03-22 | 7.02M shares derived: average of 4 quarters · filed 2022-03-22 | ||||
| 2020-12-31 | 6.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 6.52M shares derived: average of 2 quarters · filed 2022-03-22 | 6.45M shares derived: average of 3 quarters · filed 2022-03-22 | 6.39M shares 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | 6.30M shares 10-Q · filed 2021-11-12 | 6.29M shares derived: average of 2 quarters · filed 2021-11-12 | 6.27M shares 10-Q · filed 2021-11-12 | 6.16M shares derived: average of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | 6.29M shares 10-Q · filed 2021-08-12 | 6.26M shares 10-Q · filed 2021-08-12 | 6.12M shares derived: average of 3 quarters · filed 2021-08-12 | 5.55M shares derived: average of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | 6.23M shares 10-Q · filed 2021-05-11 | 6.03M shares derived: average of 2 quarters · filed 2021-05-11 | 5.31M shares derived: average of 3 quarters · filed 2021-05-11 | 4.20M shares derived: average of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | 5.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 4.84M shares derived: average of 2 quarters · filed 2021-03-16 | 3.52M shares derived: average of 3 quarters · filed 2021-03-16 | 2.85M shares 10-K · filed 2021-03-16 | ||||
| 2019-09-30 | 3.86M shares 10-Q · filed 2020-11-12 | 2.37M shares derived: average of 2 quarters · filed 2020-11-12 | 1.86M shares 10-Q · filed 2020-11-12 | 1.58M shares derived: average of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | 882.11K shares 10-Q · filed 2020-08-12 | 844.75K shares 10-Q · filed 2020-08-12 | 824.42K shares derived: average of 3 quarters · filed 2020-08-12 | 814.28K shares derived: average of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | 806.98K shares 10-Q · filed 2020-05-14 | 9.68M shares 10-Q · filed 2019-05-13 | 795.57K shares derived: average of 2 quarters · filed 2020-05-14 | 791.67K shares derived: average of 3 quarters · filed 2020-05-14 | 775.99K shares derived: average of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | 784.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 784.02K shares derived: average of 2 quarters · filed 2020-03-26 | 765.66K shares derived: average of 3 quarters · filed 2020-03-26 | 756.01K shares 10-K · filed 2020-03-26 | 9.07M shares 10-K · filed 2019-03-29 | |||
| 2018-09-30 | 783.87K shares 10-Q · filed 2019-11-14 | 9.40M shares 10-Q · filed 2018-11-09 | 756.40K shares derived: average of 2 quarters · filed 2019-11-14 | 746.63K shares 10-Q · filed 2019-11-14 | 8.96M shares 10-Q · filed 2018-11-09 | 4.74M shares derived: average of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | 728.93K shares 10-Q · filed 2019-08-14 | 8.75M shares 10-Q · filed 2018-08-10 | 727.70K shares 10-Q · filed 2019-08-14 | 8.73M shares 10-Q · filed 2018-08-10 | 6.05M shares derived: average of 3 quarters · filed 2019-08-14 | 6.72M shares derived: average of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | 8.72M shares 10-Q · filed 2019-05-13 | 8.72M shares derived: average of 2 quarters · filed 2019-05-13 | 8.72M shares derived: average of 3 quarters · filed 2019-05-13 | 8.71M shares derived: average of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | 8.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 8.72M shares derived: average of 2 quarters · filed 2019-03-29 | 8.71M shares derived: average of 3 quarters · filed 2019-03-29 | 8.67M shares 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | 8.72M shares 10-Q · filed 2018-11-09 | 8.71M shares derived: average of 2 quarters · filed 2018-11-09 | 8.65M shares 10-Q · filed 2018-11-09 | 8.57M shares derived: average of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | 8.71M shares 10-Q · filed 2018-08-10 | 8.61M shares 10-Q · filed 2018-08-10 | 8.51M shares derived: average of 3 quarters · filed 2018-08-10 | 8.63M shares derived: average of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | 8.52M shares 10-Q · filed 2018-05-15 | 8.42M shares derived: average of 2 quarters · filed 2018-05-15 | 8.61M shares derived: average of 3 quarters · filed 2018-05-15 | 8.41M shares derived: average of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | 8.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | 8.65M shares derived: average of 2 quarters · filed 2018-03-30 | 8.37M shares derived: average of 3 quarters · filed 2018-03-30 | 7.43M shares 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | 8.99M shares 10-Q · filed 2017-11-14 | 8.40M shares derived: average of 2 quarters · filed 2017-11-14 | 7.13M shares 10-Q · filed 2017-11-14 | 6.40M shares derived: average of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | 7.80M shares 10-Q · filed 2017-08-14 | 6.20M shares 10-Q · filed 2017-08-14 | 5.54M shares derived: average of 3 quarters · filed 2017-08-14 | 5.21M shares derived: average of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | 4.59M shares 10-Q · filed 2017-05-15 | 4.41M shares derived: average of 2 quarters · filed 2017-05-15 | 4.35M shares derived: average of 3 quarters · filed 2017-05-15 | 4.32M shares derived: average of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | 4.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 4.23M shares derived: average of 2 quarters · filed 2017-03-31 | 4.22M shares derived: average of 3 quarters · filed 2017-03-31 | 4.22M shares 10-K · filed 2017-03-31 | 140.40M shares 10-K · filed 2016-03-30 | |||
| 2015-09-30 | 4.23M shares 10-Q · filed 2016-11-14 | 139.62M shares 10-Q · filed 2015-11-16 | 4.23M shares derived: average of 2 quarters · filed 2016-11-14 | 4.22M shares 10-Q · filed 2016-11-14 | 139.41M shares 10-Q · filed 2015-11-16 | 71.77M shares derived: average of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | 4.22M shares 10-Q · filed 2016-08-15 | 139.30M shares 10-Q · filed 2015-08-19 | 4.22M shares 10-Q · filed 2016-08-15 | 139.30M shares 10-Q · filed 2015-08-19 | 94.28M shares derived: average of 3 quarters · filed 2016-08-15 | 104.73M shares derived: average of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | 139.30M shares 10-Q · filed 2015-05-20 | 139.32M shares derived: average of 2 quarters · filed 2016-03-30 | 138.23M shares derived: average of 3 quarters · filed 2016-03-30 | 137.68M shares derived: average of 4 quarters · filed 2016-03-30 | ||||
| 2014-12-31 | 139.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 137.69M shares derived: average of 2 quarters · filed 2016-03-30 | 137.15M shares derived: average of 3 quarters · filed 2016-03-30 | 135.90M shares 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | 136.05M shares 10-Q · filed 2015-11-16 | 136.05M shares derived: average of 2 quarters · filed 2015-11-16 | 134.75M shares 10-Q · filed 2015-11-16 | 132.00M shares derived: average of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | 136.05M shares 10-Q · filed 2015-08-19 | 134.09M shares 10-Q · filed 2015-08-19 | 130.65M shares derived: average of 3 quarters · filed 2015-08-19 | 127.95M shares derived: average of 4 quarters · filed 2015-08-19 | ||||
| 2014-03-31 | 136.05M shares 10-Q · filed 2015-05-20 | 127.95M shares derived: average of 2 quarters · filed 2015-07-20 | 125.24M shares derived: average of 3 quarters · filed 2015-07-20 | 123.89M shares derived: average of 4 quarters · filed 2015-07-20 | ||||
| 2013-12-31 | 119.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | 119.84M shares derived: average of 2 quarters · filed 2015-07-20 | 119.84M shares derived: average of 3 quarters · filed 2015-07-20 | 119.84M shares 10-K · filed 2015-07-20 | ||||
| 2013-09-30 | 119.83M shares 10-Q · filed 2014-11-14 | 119.83M shares derived: average of 2 quarters · filed 2014-11-14 | 119.83M shares 10-Q · filed 2014-11-14 | |||||
| 2013-06-30 | 119.83M shares 10-Q · filed 2014-08-14 | 119.83M shares 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | 119.83M shares 10-Q · filed 2014-05-20 | |||||||
| 2012-12-31 | 119.83M shares 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |